Cargando…
Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases
Erythropoietin (EPO) is a cytokine mainly induced in hypoxia conditions. Its major production site is the kidney. EPO primarily acts on the erythroid progenitor cells in the bone marrow. More and more studies are highlighting its secondary functions, with a crucial focus on its role in the central n...
Autores principales: | Rey, Federica, Balsari, Alice, Giallongo, Toniella, Ottolenghi, Sara, Di Giulio, Anna M., Samaja, Michele, Carelli, Stephana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712762/ https://www.ncbi.nlm.nih.gov/pubmed/31450955 http://dx.doi.org/10.1177/1759091419871420 |
Ejemplares similares
-
Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021) -
Alterations of Calcium Channels in a Mouse Model of Huntington’s Disease and Neuroprotection by Blockage of Ca(V)1 Channels
por: Miranda, Artur S., et al.
Publicado: (2019) -
Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects
por: Rey, Federica, et al.
Publicado: (2021) -
Potential Thai medicinal plants for neurodegenerative diseases: A review focusing on the anti-glutamate toxicity effect
por: Prasansuklab, Anchalee, et al.
Publicado: (2020) -
Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics
During Alzheimer’s Disease Progression
por: Findley, Caleigh A., et al.
Publicado: (2019)